HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study.

Abstract
Angiogenic factors play a role in tumor growth and spread. The object of this study was to analyze the correlation between mRNA expression of angiogenesis-related genes and disease outcome in advanced-stage ovarian carcinomas. Sections from 66 primary ovarian carcinomas and metastatic lesions from 41 patients diagnosed with advanced stage ovarian carcinoma (FIGO stages III-IV) were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8 (IL-8), and vascular endothelial growth factor (VEGF) using mRNA In Situ Hybridization (ISH). Patients were divided in two groups based on disease outcome. Long-term survivors (17 patients) and short-term survivors (24 patients) were defined using a double cut-off of 36 months for disease-free survival (DFS) and 60 months for overall survival (OS). Mean follow-up period was 70 months. The mean values for DFS and OS were 116 and 133 months for long-term survivors, as compared to 3 and 21 months for short-term survivors, respectively. Expression of bFGF mRNA, most often intense, was detected in tumor and stromal cells in the majority of cases. Weak expression of IL-8 mRNA was detected in both cell compartments, while VEGF mRNA expression was limited to few cases. Primary tumors displayed higher bFGF and IL-8 mRNA expression. However, these differences did not reach statistical significance (P > 0.05). bFGF, IL-8 and VEGF mRNA expression in both tumor and stromal cells was comparable in tumors of long-term and short-term survivors, and showed no correlation with disease outcome in survival analysis (P > 0.05). bFGF is the major angiogenic factor expressed in ovarian carcinoma at the mRNA level. mRNA expression of VEGF, bFGF, and IL-8 does not appear to be a predictor of disease outcome in advanced-stage ovarian carcinoma.
AuthorsB Davidson, I Goldberg, J Kopolovic, W H Gotlieb, V Givant-Horwitz, J M Nesland, A Berner, G Ben-Baruch, M Bryne, R Reich
JournalClinical & experimental metastasis (Clin Exp Metastasis) Vol. 18 Issue 6 Pg. 501-7 ( 2000) ISSN: 0262-0898 [Print] Netherlands
PMID11592307 (Publication Type: Journal Article)
Chemical References
  • DNA Primers
  • Endothelial Growth Factors
  • Interleukin-8
  • Lymphokines
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Fibroblast Growth Factor 2
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Base Sequence
  • DNA Primers
  • Disease-Free Survival
  • Endothelial Growth Factors (genetics)
  • Female
  • Fibroblast Growth Factor 2 (genetics)
  • Humans
  • In Situ Hybridization
  • Interleukin-8 (genetics)
  • Lymphokines (genetics)
  • Middle Aged
  • Neovascularization, Pathologic (genetics)
  • Ovarian Neoplasms (blood supply, genetics, pathology)
  • RNA, Messenger (genetics)
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: